While IHC has been successfully used to detect phospho-specific MYBL2 in human carcinomas, a more feasible approach would be to employ IHC panels detecting MYBL2 and MYBL2-regulated targets such as FOXM1, CHK1, and RAD51 (Figures 6B, 8B) (46). Here, RAD51 is linked to carcinoma.